Clinical Trials

Sarcoma

NCT07039760 2026-03-11

Asciminib With or Without Sildenafil for Brain Tumors

12 enrolled

Brain Neoplasms

NCT07460232 2026-03-10

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

50 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT07458659 2026-03-09

CART-BCMA

3 enrolled

Multiple Myeloma

NCT07458919 2026-03-09

Therapy for Advanced NSCLC With EGFR 19delins Mutation

94 enrolled

Thoracic

Lung Neoplasms

NCT07429071 2026-03-04

Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

70 enrolled

Gynecologic

Uterine Cervical Dysplasia

NCT07420036 2026-03-03

SFB6-ZN01 PET

98 enrolled

Hypersensitivity, Neoplasms

NCT07446257 2026-03-03

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

60 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT07446686 2026-03-03

Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

30 enrolled

Breast

Breast Neoplasms

NCT07210632 2026-02-27

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

38 enrolled

Brain Neoplasms, Glioma

NCT07318389 2026-02-27

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

100 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07439120 2026-02-27

Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

Genitourinary

Carcinoma, Transitional Cell

NCT07416682 2026-02-25

CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms

High-risk Plasma Cell Neoplasms

NCT07429721 2026-02-24

A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.

24 enrolled

Multiple Myeloma

NCT05676489 2026-02-20

MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors

28 enrolled

Glioma

NCT07408193 2026-02-20

The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.

24 enrolled

Cancer Pain, Opioid-Related Disorders, Neoplasms

NCT07286318 2026-02-19

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

GastrointestinalGynecologicOther solid neoplasmThoracic

24 enrolled

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT07319195 2026-02-18

WINIT-BC

32 enrolled

Breast

Breast Neoplasms

NCT07071155 2026-02-11

M-HArbOr

MyeloidOther hematologic neoplasm

18 enrolled

Myelodysplastic Syndromes, Leukemia, Neutrophilic, Chronic, Leukemia, Myelomonocytic, Chronic

NCT07392528 2026-02-11

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

15 enrolled

Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica

NCT04016818 2026-02-10

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

Breast

Breast Neoplasms

NCT07399444 2026-02-10

LB2505-0001

38 enrolled

Multiple Myeloma

NCT07396714 2026-02-09

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

88 enrolled

Warts

NCT07387666 2026-02-06

Imaging Acetadote Metabolism in Glioblastoma

Glioblastoma

NCT07394205 2026-02-06

Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer

18 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07389174 2026-02-05

Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer

40 enrolled

Genitourinary

mHSPC

NCT07389187 2026-02-05

Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

mCRPC

NCT07389525 2026-02-05

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

DermatologicGastrointestinalSarcoma

80 enrolled

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

NCT07381582 2026-02-02

161Tb-LNC1011

15 enrolled

Genitourinary

Prostatic Neoplasms

NCT06828588 2026-01-29

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

30 enrolled

BreastGastrointestinal

Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT07065552 2026-01-28

Tirzepatide in Obesity-Driven Endometrial Cancer

GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms

NCT07362602 2026-01-23

Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies

47 enrolled

Hematologic Neoplasms

NCT07362732 2026-01-23

Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection

Hematologic Neoplasms

NCT07358195 2026-01-22

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

3 enrolled

Hematologic Neoplasms, Renal Insufficiency, Chronic

NCT07185490 2026-01-20

IASO104

Other hematologic neoplasmPlasma cell

40 enrolled

Leukemia, Plasma Cell, Multiple Myeloma

NCT07146893 2026-01-15

FEATHER

7 enrolled

Cachexia-Anorexia Syndrome

NCT07338357 2026-01-13

Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

Leukemia, Myeloid, Acute

NCT07332663 2026-01-12

Exploratory Study on the Treatment of Relapsed and Refractory B-cell Malignant Tumors With WGb-0301 Injection

9 enrolled

B Cell Malignancies

NCT07335094 2026-01-12

A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

60 enrolled

Lymphoid

Lymphoma

NCT07330895 2026-01-09

Clinical Study of LV009 Injection in the Treatment of Recurrent/Refractory CD19 Positive Blood Tumors

19 enrolled

Recurrence

NCT07325123 2026-01-08

Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors

30 enrolled

Other solid neoplasm

Solid Tumor Malignancies

NCT07322159 2026-01-07

IASO206 in Patients With Relapsed/Refractory Multiple Myeloma

12 enrolled

Multiple Myeloma

NCT06789081 2025-12-15

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)

1 enrolled

Sarcoma

Sarcoma, Alveolar Soft Part

NCT07277504 2025-12-11

Autologous Bedside CD19 CAR T-cell Therapy for B-ALL

50 enrolled

Lymphoid

Burkitt Lymphoma

NCT07272603 2025-12-09

Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer

5 enrolled

Tumor-Agnostic

Neoplasms

NCT07261657 2025-12-03

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

8 enrolled

Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

NCT07256353 2025-12-01

Allogeneic UCB-derived CAR-T for B-ALL

50 enrolled

Lymphoid

Burkitt Lymphoma

NCT07244666 2025-11-24

Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma

36 enrolled